Human Insulin (HI) Market to Witness the Highest Growth Globally in Coming Years

09/mag/2019 06:47:15 Pramod Kumar Contatta l'autore

Questo comunicato è stato pubblicato più di 3 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Increasing population exposure to key factors leading to diabetes, technological advancements in insulin delivery devices, growth in the number of diabetic patients, and growing population problems.

HI drugs are further classified into analogs and biologics. There are various brands available for HI analogs and biologics. The HI analogs are also classified on a basis of rapid-acting, long-acting, and premixed insulin. Similarly, HI biologics are bifurcated into intermediate / rapid-acting, short-acting, premixed, on the basis of type. Among these, short-acting insulin is predicted to be the fastest growing category in the global market, demonstrating at CAGR of 5.8%.

 

Download Sample of This Research Report:    https://www.psmarketresearch.com/market-analysis/human-insulin-market/report-sample

The human insulin market is categorized into type II diabetes, type I diabetes, and gestational diabetes and prediabetes. Type II diabetes is expected to be the fastest growing application area in this market, advancing at CAGR of 9.1% during the forecast period, which is to increase prevalence of diabetes, globally.

Furthermore, the World Health Organization (WHO) developed the action plan for the prevention and control of non-communicable diseases (NCDs) in South-East Asia 2013–2020. The plan is to provide roadmaps for the implementation of regional level programs, thus fueling human insulin market growth in the region.

In order to increase their market share, they are pursuing partnerships and collaborations. For instance, in October 2018, Ypsomed AG collaborated with Koninklijke Philips NV (Philips) to jointly develop and deploy new digital self-medication adherence monitoring services based on Ypsomed's connected devices and Philips' cloud based HealthSuite digital platform.

Make Inquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=human-insulin-market

Some of the other key players operating in the human insulin industry are B. Braun Melsungen AG; Becton, Dickinson and Company; Eli Lilly and Company; Novo Nordisk A / S; Sanofi; Wockhardt Limited; Biocon Limited; Medtronic plc; and Gulf Pharmaceutical Industries (Julphar).

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P & S as an enterprising research and consulting company, believes in providing thorough analysis on the ever-changing market scenario, to empowering companies to make informed decisions and base their business strategies with astuteness.

Contact:

P&S Intelligence

Toll-free: + 1-888-778-7886 (USA / Canada)          

International: + 1-347-960-6455

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Facebook

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl